Pasithea Therapeutics Corp. Financial Ratios
KTTA|FY2022 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2022 SEC 10-K data.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.26 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2022)
Return on Equity
-4.2%
Profit Margin
-14430.5%
Net Income / Revenue
Asset Turnover
0.00
Revenue / Total Assets
Equity Multiplier
0.88
Total Assets / Equity
Composite: -4.2% (reported: -4.2%)
Profitability
Liquidity
Current Ratio
18.15
Quick Ratio
18.15
Solvency
Interest Coverage
-6248.15
Efficiency
Asset Turnover
0.00
Inventory Turnover
-
Days Sales Outstanding
-
As of FY2022 · SEC 10-K · Updated Jun 28, 2026
Earnings Quality
Accrual Ratio
+2.0%
+2.0pp YoY
Earnings are roughly in line with operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.